Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.
第一作者:
Iacopo,Olivotto
第一单位:
From the Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy (I.O.); Gilead Sciences, Inc, Foster City, CA (J.L.H., R.F.-F., C.B., L.B.); Department of Preclinical and Clinical Pharmacology and Center of Molecular Medicine, University of Florence, Florence, Italy (R.C.); Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto, CA (J.M.); and Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA (M.S.M.). olivottoi@aou-careggi.toscana.it.
作者:
主题词
澳大利亚(Australia);心肌病, 肥厚性(Cardiomyopathy, Hypertrophic);临床方案(Clinical Protocols);双盲法(Double-Blind Method);欧洲(Europe);运动耐量(Exercise Tolerance);人类(Humans);以色列(Israel);功能恢复(Recovery of Function);研究设计(Research Design);钠通道阻滞剂(Sodium Channel Blockers);时间因素(Time Factors);治疗结果(Treatment Outcome);美国(United States)
DOI
10.1161/CIRCHEARTFAILURE.115.002764
PMID
26915375
发布时间
2018-08-10
- 浏览53

Circulation. Heart failure
e002764页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文